Abstract
Mitochondrial dysfunction causes devastating disorders, including mitochondrial myopathy. Here, we identified that diverse mitochondrial myopathy models elicit a protective mitochondrial integrated stress response (mt-ISR), mediated by OMA1-DELE1 signaling. The response was similar following disruptions in mtDNA maintenance, from knockout of Tfam, and mitochondrial protein unfolding, from disease-causing mutations in CHCHD10 (G58R and S59L). The preponderance of the response was directed at upregulating pathways for aminoacyl-tRNA biosynthesis, the intermediates for protein synthesis, and was similar in heart and skeletal muscle but more limited in brown adipose challenged with cold stress. Strikingly, models with early DELE1 mt-ISR activation failed to grow and survive to adulthood in the absence of Dele1, accounting for some but not all of OMA1’s protection. Notably, the DELE1 mt-ISR did not slow net protein synthesis in stressed striated muscle, but instead prevented loss of translation-associated proteostasis in muscle fibers. Together our findings identify that the DELE1 mt-ISR mediates a stereotyped response to diverse forms of mitochondrial stress and is particularly critical for maintaining growth and survival in early-onset mitochondrial myopathy.
Introduction
Mitochondria generate energy through oxidative phosphorylation (OXPHOS) (Classics Mitchell, 1966). They are also important for cell growth and maintenance, compartmentalizing amino acid synthesis and one carbon (1C) metabolism pathways to generate biosynthetic intermediates (Zong et al, 2016). The biosynthetic and energetic functions of mitochondria are coupled through redox equivalents such as NADH, and cell growth can be limited by OXPHOS inhibition even in the setting of sufficient ATP production (Luengo et al, 2021).
Maintaining optimal OXPHOS is thus important for cell maintenance and growth but is also complicated by the intricacy of the OXPHOS system. In OXPHOS, energy from fuels like glucose and fatty acids are initially transferred to redox equivalents by the tricyclic acid (TCA) cycle (and other pathways) and fed into the electron transport chain (ETC), composed of four inner mitochondrial membrane (IMM) embedded complexes (Chandel, 2021). The ETC uses redox energy from these reducing equivalents to pump protons across the IMM. The IMM stores this potential energy in an electrochemical gradient, which then tunnels protons through the F1FO-ATP synthase to drive ATP synthesis. Damage to any component of this IMM-embedded system, including the IMM itself, can potentially hobble the mitochondrial production of ATP and biosynthetic intermediates.
Indeed, mutations in over 250 genes cause primary mitochondrial disorders, presenting often as mitochondrial myopathy (Mayr et al, 2015), and often with abnormal growth and short stature (Boal et al, 2019). Some of these likely damage the IMM through protein unfolding stress, as we and others recently demonstrated for mutations in the nuclear DNA (nDNA)-encoded intermembrane space (IMS) protein CHCHD10, causing Dominant Inherited Mitochondrial Myopathy (IMMD) (Shammas et al, 2022; Ajroud-Driss et al, 2015; Bannwarth et al, 2014; Genin et al, 2019; Anderson et al, 2019). Others cause severe OXPHOS deficiency through either mutations in the mitochondrial DNA (mtDNA) itself or the machinery needed to express the thirteen mtDNA-encoded OXPHOS subunits (Zeviani et al, 1989; Holt et al, 1988; Spelbrink et al, 2001; Goethem et al, 2001). Mutations affecting mtDNA or its expression account for most mitochondrial myopathy cases (Gorman et al, 2015). The mechanisms of mitochondrial damage can thus be diverse, but they likely have in common disruption of OXPHOS and its coupled biosynthetic pathways. Patient survival may depend on how well striated muscle adapts to these disruptions in mitochondrial metabolism (Hathazi et al, 2020).
One form of adaptation to mitochondrial stress is mediated through retrograde mitochondria-to-nucleus (mitonuclear) signaling. The first mitonuclear signal in mammalian cells was identified in the setting of mitochondrial protein unfolding stress and was named the mitochondrial unfolded protein response (mt-UPR) (Zhao et al, 2002). Subsequently, an amino acid starvation-like response was identified in mouse models with defects in mtDNA maintenance (e.g., mutations in Twinkle or Tfam) or mtDNA expression (e.g., mutations in Dars2) causing severe OXPHOS deficiency (Tyynismaa et al, 2010; Dogan et al, 2014; Kühl et al, 2017). Responses like these were initially attributed to energy and amino acid sensing pathways outside of the mitochondria, with upstream signaling from AKT, mTOR, and/or GCN2, converging on transcription factors such as ATF4, ATF5, and CHOP (Tyynismaa et al, 2010; Khan et al, 2017; Mick et al, 2020). Related work emphasized the imbalance between mtDNA and nDNA encoded OXPHOS subunits in the setting of diminished mtDNA expression as a mitonuclear signal (Houtkooper et al, 2013). However, it is not known whether these responses to different forms of mitochondrial stress are mediated by a common molecular signaling pathway in vivo or if they reflect distinct molecular pathways signaling distinct stresses, such as mitochondrial protein unfolding vs. mitonuclear imbalance.
In cultured cells, one of these mitonuclear signals is the OMA1-DELE1-HRI-eIF2α-ATF4 signaling cascade (hereafter, the DELE1 mt-ISR) (Fessler et al, 2020; Guo et al, 2020). Recently, we demonstrated that the OMA1-DELE1 pathway can also signal the mt-ISR in vivo, in response to protein misfolding of CHCHD10 with the IMMD-causing mutation (Shammas et al, 2022). We additionally found that the OMA1-dependent stress response is strongly protective in the IMMD model. Similar findings were independently reported for two other cardiomyopathy models (one from conditional knockout (KO) of a Complex IV subunit, COX10 (Ahola et al, 2022), and the other from KO of the cardiolipin remodeling protein Tafazzin (Huynh et al, 2022; Zhu et al, 2022)), together supporting the idea that the DELE1 mt-ISR mediates at least some mitochondria-to-nucleus signaling in response to mitochondrial stress in vivo. However, it is not known whether there is a common OMA1-DELE1 stress pathway responding to diverse mitochondrial stressors, such as protein unfolding and mtDNA maintenance. Additionally, the mt-ISR has not been examined in skeletal muscle, the tissue that is primarily affected in mitochondrial myopathies.
Here, we provide a comprehensive view of the OMA1-DELE1 stress response in vivo, using a novel Dele1 KO mouse subjected to four diverse mitochondrial stressors in striated muscle, including protein unfolding stress (mutant CHCHD10 protein unfolding) and severe mitonuclear imbalance from a defect in mtDNA maintenance (Tfam KO) (Hansson et al, 2004). Using a multi-omics approach, we identified that DELE1 mediates a stereotyped transcriptional response to these diverse mitochondrial stressors to maintain biosynthetic pathways, particularly protein synthesis. This response was similar in cardiac and skeletal muscle and partially overlapped with the physiologic DELE1-dependent response we uncovered in brown adipose tissues (BAT) subjected to cold stress. Although protective in all myopathy/cardiomyopathy models tested, the DELE1 mt-ISR provided dramatically increased survival in two myopathy/cardiomyopathy models with stress onset during early postnatal growth, underscoring the importance of the mt-ISR for promoting anabolism in the face of mitochondrial stress. Importantly, the DELE1 mt-ISR signature was observed in skeletal muscle from patients with mitochondrial myopathy from several prior independent studies, together suggesting that the DELE1 mt-ISR is a critical response for maintaining striated muscle in mitochondrial myopathy.
Results
DELE1 mediates the mt-ISR in response to physiologic stress
We previously found that OMA1 promotes survival in a model of early-onset mitochondrial myopathy (Shammas et al, 2022). OMA1 activates the mt-ISR by cleaving DELE1, generating a short form of DELE1 (S-DELE1) (Fessler et al, 2020; Guo et al, 2020). S-DELE1, in turn, activates HRI to phosphorylate eIF2α, thereby triggering the ISR (Fig. 1A, top). The ISR acutely slows protein synthesis overall, by decreasing the rate of translation initiation, but allows for the preferential translation of transcription factors with upstream open reading frames such as ATF4, causing global changes in gene expression (Pakos-Zebrucka et al, 2016; Wek, 2018).
To isolate the effects of OMA1 on the mt-ISR, we generated a constitutive Dele1 KO mouse by CRISPR-Cas9 genome editing (Fig. 1A, bottom). No antibodies are currently available to detect endogenous DELE1, however, we verified that the mutation destabilizes Dele1 mRNA in several tissues, including brown adipose tissue (BAT), heart, gastrocnemius skeletal muscle, and liver, likely by nonsense mediated decay (Fig. 1B). Additionally, the predicted truncated protein product (resulting from the predicted frameshift mutation p.Arg21GInfsTer19), if expressed, would lack part of the targeting sequence needed for mitochondrial localization and the tetratricopeptide repeat (TPR) domains required for HRI binding and downstream signaling (Yang et al, 2023).
Dele1 KO mice appeared grossly normal with similar body weight to wildtype (WT) mice up to at least 4 – 6 months of life (Fig. 1C), and the heart mitochondrial proteome was not significantly altered by Dele1 KO (Fig. 1D). Consistently, mitochondria from WT and Dele1 KO hearts were indistinguishable by thin section transmission electron microscopy (TEM) at 28 days (Fig. 1E), with similar median areas (0.57 vs. 0.61 µm2) and aspect ratios (1.47 vs. 1.50) (Fig. 1F and G). Together, these findings suggest that Dele1 KO does not disrupt mitochondria in the absence of mitochondrial stress.
We next considered whether DELE1 may be responsible for physiologic stress responses downstream of OMA1. We focused on cold stress in the heat-producing BAT, as cold stress has been shown to activate OMA1 and, in separate reports, cold stress has been reported to activate the ISR (Quirós et al, 2012; Jena et al, 2023; Flicker et al, 2019; Levy et al, 2023). Given OMA1 can be activated by mitochondrial uncouplers (Ehses et al, 2009; Head et al, 2009), activation of OMA1 in this setting is likely due to the fatty acid driven uncoupled mitochondrial respiration that produces heat (Nicholls, 2023). A 9-hour cold stress reduced BAT lipid droplets in WT, Oma1 KO, and Dele1 KO mice, as expected, indicating fatty acid consumption by mitochondria to support uncoupled respiration (Supplemental Fig. 1A). Additionally, OMA1 was activated to cleave L-OPA1 in WT and Dele1 KO mice, producing the OMA1 specific cleavage products c and e from a and b, respectively (d is produced by cleavage of a by a different protease, YME1) (Fig. 1H) (Ehses et al, 2009; Head et al, 2009; Song et al, 2007). As expected, L-OPA1 cleavage was blocked by OMA1 KO (Supplemental Fig. 1B), confirming prior observations that OMA1 cleaves L-OPA1 in the setting of cold stress.
To determine whether DELE1 mediates the ISR, we assessed global gene expression in BAT. We reasoned that DELE1-dependent differentially expressed genes (DEGs) should change with stress in WT but not in Dele1 KO mice. Intersecting the significant upregulated and downregulated DEGs from two comparisons (WT: stress vs. no stress, and Stress: Dele1 WT vs. Dele1 KO) (Supplemental Fig. 1C), we identified 11 DELE1-dependent DEGs, nearly all of which were genes classically associated with the ISR response, including Mthfd2, Cth, Fgf21, Chac1, Psat1, Slc7a1, Slc7a5, Cars, and Tars (Fig. 1I and J). For each gene, we also calculated the proportion of gene expression change that was attributable to DELE1 (% DELE1 dependence). This ranged from 70 - 97% for individual genes, indicating that DELE1 drives most of the gene expression changes in this set (Fig. 1J, right). Upregulation of these genes by stress was also largely dependent on OMA1, consistent with OMA1 functioning upstream of DELE1 in this pathway (Fig. 1J). As HRI mediates the ISR downstream of DELE1, this also explains why Gcn2 KO in BAT did not block this response in a recent study (Levy et al, 2023). As expected, Dele1 KO did not change gene expression in the non-stressed condition relative to WT (kept at room temperature) (Supplemental Fig. 1D). Thus, we identified the first DELE1-dependent physiologic stress: activation of the ISR in BAT in response to cold stress.
DELE1 activates the mt-ISR in response to diverse mitochondrial stressors in striated muscle to promote growth and survival
We next asked whether DELE1 is responsible for the mt-ISR in response to diverse mitochondrial stressors. To address this question, we crossed the Dele1 KO mouse with four different mouse models of mitochondrial myopathy/cardiomyopathy: two knock-in (KI) models of dominant mitochondrial myopathies Chchd10G58R/WT (hereafter, C10 G58R) and Chchd10S59L/WT (hereafter, C10 S59L) (Shammas et al, 2022; Genin et al, 2019; Anderson et al, 2019; Liu et al, 2020); and two KO models, Chchd2/Chchd10 double KO (hereafter, C2/C10 DKO) and Tfam skeletal and cardiac muscle conditional knockout (Tfamfl/fl; Ckmm-Cre; hereafter, Tfam mKO) (Hansson et al, 2004; Liu et al, 2020; Nguyen et al, 2022) (Fig. 2A - L).
Importantly, the primary mitochondrial stress was different in each model. Tfam mKO is the prototypical model of OXPHOS deficiency due to a defect mtDNA maintenance (Hansson et al, 2004). This model is also predicted to induce severe mitonuclear imbalance, as expression of mtDNA encoded OXPHOS subunits is blocked but expression of nDNA encoded OXPHOS subunits is unaffected. C10 G58R and C10 S59L, by contrast, are models of intramitochondrial protein misfolding, and are not predicted to differentially effect levels of mtDNA and nDNA encoded OXPHOS subunits (Shammas et al, 2022; Genin et al, 2019; Anderson et al, 2019; Liu et al, 2020). The C10 G58R and S59L mutations cause CHCHD10 to misfold into two distinct toxic conformations within the mitochondria IMS with differential impacts on the mitochondria and the overall phenotype (Shammas et al, 2022). C10 G58R has an earlier and more severe impact on skeletal muscle than C10 S59L, leading to early-onset mitochondrial myopathy in both mice and humans (Shammas et al, 2022; Ajroud-Driss et al, 2015; Heiman-Patterson et al, 1997; Bannwarth et al, 2014; Anderson et al, 2019; Genin et al, 2019). C2/C10 DKO likely also disrupts mitochondrial cristae proteostasis but has a milder phenotype than protein misfolding from C10 G58R and C10 S59L (Liu et al, 2020; Huang et al, 2018). Indeed, the C2/C10 DKO are remarkable for having a near normal lifespan and healthspan, despite having early and pervasive activation of the mt-ISR (Liu et al, 2020; Nguyen et al, 2022).
Despite the diversity of the underlying stress, DELE1 was protective in each of the four models (Fig. 2C, F, I, and L). The survival benefit was especially pronounced for the C2/10 DKO and C10 G58R models (Fig. 2C and F), which also had the earliest activation of the mt-ISR, indicated by elevation of the maker protein MTHFD2 by postnatal day 14 (P14) (Fig. 2M and N). Strikingly, the C2/C10 DKO, which have a near normal lifespan and healthspan in the presence of DELE1 (Liu et al, 2020; Nguyen et al, 2022), lived a median of 10 days without DELE1 (Fig. 2C). Similarly, C10 G58R mice, which have a median life expectancy of more than 18 months with DELE1 (Shammas et al, 2022), survived a median of 1 month in the absence of DELE1 (Fig. 2F).
The early death in these models correlated with decreased growth in the first weeks of life. C2/C10/Dele1 triple KO mice had a similar weight as their siblings at birth, but their weight gain slowed from P4 (Fig. 2B). Similarly, weights of C10 G58R; Dele1 KO mice were reduced relative to their littermates at 21 days and did not further increase from P21 to P28 (Fig. 2E). The failure to gain body mass also correlated with decreased motor function: C10 G58R; Dele1 KO mice had decreased grip strength and an increased composite phenotype score compared to their C10 G58R; Dele1+ (either +/+ or +/-) siblings at 28 days (Supplemental Fig. 2A). Hand feeding only modestly increased survival of C10 G58R; Dele1 KO mice (by 10 days), suggesting that food access was a minor contributor to their failure to thrive (Supplemental Fig. 2B). Hypertrophic growth of skeletal muscle accounts for about half of the 8-fold body mass increase in the first three weeks of life (White et al, 2010; Gokhin et al, 2008), and so we examined muscle fiber hypertrophy by measuring the cross-sectional area (CSA) of muscle fibers in the gastrocnemius muscle. Consistent with a decrease in skeletal muscle hypertrophy, body weights directly correlated with muscle fiber CSA among littermates in the C10 G58R; Dele1 KO litters (r2 = 0.7272; Supplemental Fig. 2C). Thus, in the two myopathy/cardiomyopathy models with early DELE1 mt-ISR activation, early death correlated with decreased growth in the early weeks of life and worsening motor function.
In the other two models, Tfam mKO and C10 S59L, the mt-ISR was activated later: after P14 for Tfam mKO and after P28 for C10 S59L (Fig. 2M and N). The late activation of the mt-ISR in Tfam mKO mice likely reflects the postnatal expression of Cre from the Ckmm promoter, which has been estimated to recombine floxed alleles in heart and skeletal muscle between P7 and P21 (He et al, 2010). Late activation of the mt-ISR in C10 S59L mice is likewise consistent with our prior observations that C10 S59L reaches a higher protein abundance and takes longer to trigger an OMA1 stress response in both cultured cells and heart tissue compared to C10 G58R (Shammas et al, 2022). Body weights of Tfam mKO and C10 S59L were similar in the presence or absence of DELE1 (Fig. 2H and K). However, their heart to body weight ratio were significantly higher in the absence of DELE1 (Supplemental Fig. 2D and E), suggesting exacerbation of cardiomyopathy as the likely cause of early mortality in the absence of DELE1 (Fig. 2I and L).
Considered together, these findings suggest that the DELE1 mt-ISR is generally protective against diverse sources of mitochondrial stress in striated muscle and may be particularly critical when mitochondrial stress is present in striated muscle during early postnatal growth (Supplemental Fig. 2F).
DELE1 functionally overlaps with OMA1 to protect against CHCHD10 myopathy
Next, we utilized the strong phenotype observed for C10 G58R; Dele1 KO mice to genetically dissect the OMA1-DELE1 pathway. OMA1 has multiple substrates in addition to DELE1 in the mitochondria, including most notably the mitochondrial fusion protein OPA1 (Ehses et al, 2009; Head et al, 2009) (Fig. 1A). It is not known if the DELE1 mt-ISR confers all the survival benefit of the OMA1 stress response or whether cleavage of other substrates such as OPA1 also promotes survival. Additionally, recent cellular studies suggest that while OMA1 facilitates DELE1 signaling, in some settings DELE1 can signal the mt-ISR without cleavage by OMA1 (Sekine et al, 2023; Fessler et al, 2022). This would predict that Dele1 KO may have a stronger effect on the mt-ISR than Oma1 KO but this has not yet been tested in vivo. To address these questions, we directly compared the phenotypes of Dele1 KO and Oma1 KO mice under mitochondrial stress from C10 G58R protein misfolding, in litters triple mutant for C10 G58R, Dele1, and Oma1 (Fig. 3A).
In these litters, Oma1 KO had a substantially stronger effect on survival than Dele1 KO (median survival 6.5 vs. 35 days), demonstrating that the Oma1 stress response protects through multiple mechanisms, in addition to its activation of the DELE1 mt-ISR (Fig. 3A).
To identify additional mechanisms of OMA1 protection, we genetically blocked OMA1 from cleaving its other major substrate, OPA1, by generating a novel transgenic mouse line in which the preferred OMA1 cleavage site within OPA1, s1, is deleted (Ishihara et al, 2006) (Fig. 3B and Supplemental Fig. 2G). In primary fibroblasts from Opa1Δs1/Δs1 mice, the s1 deletion blocked basal cleavage and mitigated (but did not completely block) stress-induced cleavage by OMA1 (Supplemental Fig. 2G). The residual cleavage under stress is consistent with prior reports and suggests that OMA1 can cleave OPA1 at other sites in the absence of s1, albeit less efficiently (Ishihara et al, 2006). We next crossed Opa1Δs1/Δs1 and C10 G58R mice. Elimination of the s1 site reduced OMA1 cleavage of L-OPA1 both basally and in response to C10 G58R protein misfolding stress; cleavage of the b band to the e band was reduced by approximately 56% under basal conditions and 36% with C10 G58R stress, based on the e/b ratio (Fig. 3B). Partially blocking OPA1 cleavage in C10 G58R mice reduced body weight (significantly in male but not female mice) and grip strength at 13 weeks, suggesting that OPA1 cleavage by OMA1 is important for maintaining muscle function (Fig. 3C). However, the overall effect on C10 G58R mice was less pronounced than the effect of Oma1 KO or Dele1 KO, and the composite phenotype score and median survival were not significantly reduced (Fig. 3D and Supplemental Fig. 2H). The weak effect of the Opa1 Δs1 allele is likely due to its incomplete block of OMA1 cleavage, although it is also possible OMA1 protects by cleaving other substrates in addition to OPA1 and DELE1. Nonetheless, these results suggest that cleavage of OPA1 by OMA1 is protective in vivo, independent of its activation of the mt-ISR.
We next considered whether DELE1 also retains some of its function in the absence of OMA1. We previously observed that approximately a quarter of C10 G58R; Oma1 KO mice escape neonatal lethality and, surprisingly, have upregulation of mt-ISR-associated genes in the heart at 14 weeks (Shammas et al, 2022). This contrasted with knockdown of Oma1 in adult C10 G58R animals, which reliably suppressed the mt-ISR associated genes (Shammas et al, 2022). Using gene expression analysis, we assessed whether the same genes could also be activated in the absence of DELE1. Notably, all C10 G58R; Dele1 KO animals failed to activate this prespecified mt-ISR gene signature (Fig. 3E), including one outlier that survived to 16 weeks, close to the age of C10 G58R; Oma1 KO mice with an activated ISR (Supplemental Fig. 2I). Consistent with the idea that DELE1 retains some limited function independent of OMA1, the C10 G58R; Dele1 KO; Oma1 KO triple mutants died earlier than the double mutant animals (Figure 3A, yellow vs. blue and red lines). Together these findings demonstrate that DELE1 is strictly required for activation of the mt-ISR in the setting of mitochondrial myopathy, in sharp contrast to OMA1. Thus, OMA1 and DELE1 have overlapping but separable protective effects on striated muscle in vivo.
DELE1 mt-ISR has minor effects on OXPHOS complex subunits and mitochondrial structure
Next, to better understand how the DELE1 mt-ISR mediates protection against mitochondrial dysfunction, we considered whether the DELE1 mt-ISR corrects the underlying mitochondrial defect caused by stress in each myopathy/cardiomyopathy model.
The diversity of the models of myopathy/cardiomyopathy was reflected in the mitochondrial proteome and ETC complex activities resulting from C10 G58R protein misfolding stress vs. impaired mtDNA maintenance in the absence of TFAM (Fig. 3F – K and Supplemental Fig. 3A).
Tfam mKO, which causes decreased levels of mtDNA and mtDNA expression, resulted in the largest decrease in OXPHOS protein levels among the models (Fig. 3F, top, and Supplemental Fig. 3A). The average abundance of CI and CIV subunits was reduced to 31% and 43%, respectively, relative to controls (Fig. 3F, top). Consistently, CI, CIII, and CIV subunits were significantly enriched among MitoCarta3.0 Tier 3 pathways (Supplemental Fig. 3B). As expected, mtDNA-encoded subunits were significantly more downregulated than nDNA-encoded subunits in Tfam mKO hearts (Fig. 3F, gray vs. yellow data points; Fig. 3I), consistent with the primary defect in the expression of mtDNA-encoded subunits and mitonuclear protein imbalance. Mito-Ribosome and CoQ biosynthesis enzymes were also reduced, except for Pdss1 which is known to increase following disruption of CoQ biosynthesis pathway (Kühl et al, 2017).
C10 G58R, by contrast, led to a milder decrease in CI and CIV subunits (reduced to 72% and 93%, respectively, relative to controls) (Fig. 3G, top, and Supplemental Fig. 3A). The nDNA and mtDNA encoded subunits were similarly affected, suggesting that mtDNA expression was not limiting for OXPHOS protein expression and that C10 G58R does not induce a state of mitonuclear protein imbalance, in contrast to Tfam mKO (Fig. 3I). The OXPHOS complexes were least affected in adult C2/C10 DKO mice, which did not significantly decrease OXPHOS subunit expression (average CI and CIV subunit abundances were 91% and 107% of control levels, respectively) (Fig. 3H), and had comparatively mild effects on mitochondrial CI and CIV activities, with modestly decreased CI function (Fig. 3K).
Notably, Dele1 KO did not significantly change OXPHOS subunit levels or CI or CIV activities in either C10 G58R or Tfam mKO models (Fig. 3F and G, bottom, Fig. 3J, and Supplemental Fig. 3A), suggesting that the underlying mitochondrial stress is distinct among models and is not resolved by the DELE1 mt-ISR.
We next examined the ultrastructure of heart mitochondria by thin section TEM. Mitochondria in TEM micrographs were analyzed using a combination of deep-learning segmentation and manual scoring of key morphological features in >600 mitochondria per genotype (8,923 mitochondria evaluated in total) (scheme depicted in Fig. 4A). As expected, the morphological defects were highly diverse among the four models, reflecting the diversity of the underlying mitochondrial stress. However, each model caused disruption of the cristae and the contiguous IMM, the site of both OXPHOS and OMA1 sensing of mitochondrial stress (Fig. 4B-F).
The C10 G58R model showed three prominent classes of abnormal mitochondria by thin section TEM: mitochondria with inclusions composed of cristae membranes (18% of mitochondria); nano-mitochondria, defined as measuring < 250 nm in their minor axis with an aspect ratio less than 1.5 (6% of mitochondria); and electrolucent mitochondria characterized by an enlarged matrix area absent of electron-dense substance and fewer cristae (5% of mitochondria) (Fig. 4C, G, and Supplemental Fig. 4), similar to the phenotype we observed previously (Shammas et al, 2022). The electrolucent mitochondria were sometimes segmented into two parts with an electrolucent portion separated by a cut-through cristae from an area of typical matrix and cristae density (Figure 4C, bottom and Supplemental Fig. 4H, bottom). These segmented mitochondria may originate from failed fusion between inner membranes, following successful fusion between outer membranes of electrolucent and normal mitochondria, as has been observed in the setting of Opa1 KO (Hu et al, 2020). Consistent with this interpretation, the segmented mitochondria were approximately twice as large (in cross-section) as the unsegmented electrolucent mitochondria in our dataset (Supplemental Fig. 4B). Interestingly, mitochondrial ultrastructure in adult C2/C10 DKO hearts resembled that of C10 G58R, but with decreased frequency of cristal inclusions (4% of mitochondria) and electrolucent mitochondria (2% of mitochondria) (Fig. 4D, H, and Supplemental Fig. 5). This suggests that loss of C2/C10 function and C10 G58R misfolding may exert a similar stress on the IMM, which is more severe in the adult heart with C10 G58R misfolding.
Notably, similar proportions of nano-mitochondria and cristal inclusions were observed in C10 G58R mice in the presence or the absence of one copy of Dele1 (Fig. 4G). Consistently, the average area of mitochondria was similar in the presence and absence of Dele1 (Supplemental Fig. 4A). Electrolucent mitochondria were more frequent in the absence of Dele1 (Fig. 4G), phenocopying a trend we observed previously for the effect of Oma1 KO on electrolucent mitochondria (Shammas et al, 2022). These electrolucent mitochondria were also more likely to undergo outer membrane rupture and mitophagy, events that were observed almost exclusively in the absence of Dele1 (Fig. 4G and Supplemental Fig. 4I and J). These results suggest that the DELE1 mt-ISR may be protective against the formation of electrolucent mitochondria in response to C10 G58R protein misfolding but did not affect other mitochondrial phenotypes, such as mitochondrial fragmentation and cristal inclusions, observed in C10 G58R mice.
In contrast to C10 G58R mice, the C10 S59L mice had few intracristal inclusions and electrolucent mitochondria, suggesting that C10 S59L exerts a different stress on mitochondria than C10 G58R, despite the proximity of the mutations (Fig. 4E, I, and Supplemental Fig. 6). Instead, the outer mitochondrial membrane (OMM) of C10 S59L mitochondria were more frequently ruptured and partially or fully enclosed by double-membraned autophagophores or autophagosomes, respectively, as has also been reported previously by others (Genin et al, 2019) (Fig. 4E, I, and Supplemental Fig. 6E and F). C10 S59L also had the highest frequency of nano-mitochondria (22%) in thin sections among the models (Fig. 4I). Tracking nano-mitochondria through several 60 nm-thick serial sections showed that some were indeed spherical, while others were short tubules (Supplemental Fig. 5G and H), but most were nano-tubes emerging from larger mitochondria and ending in a dead-end or connecting to other mitochondria. Similar numbers of OMM rupture and mitophagy events were observed in the presence or absence of Dele1, whereas fewer nano-mitochondria were observed in the absence of Dele1 (Fig. 4I). The average area of mitochondria was similar in the presence and absence of Dele1 (Supplemental Fig. 4A). Thus, the DELE1 mt-ISR did not prevent the mitochondrial morphological defects caused by C10 S59L protein misfolding stress.
Mitochondria from adult Tfam mKO hearts also had a distinct ultrastructure, compared to the other three models, suggesting loss of mtDNA exerts a different stress on mitochondria than C10 protein misfolding or C2/C10 DKO (Fig. 4F, J, and Supplemental Fig. 7). In Tfam mKO, mitochondrial cristae often appeared to adhere together forming patches of typically five or more “stacked” cristae, with little intralumenal space. Often, in the same mitochondrion, large regions of homogenous light gray matrix material were devoid of cristae, in a “sparse cristae” phenotype. Cristae that were crumpled into electron dense swirls were also observed, as well as cristae that appeared tubular, with increased diameter (Fig. 4F and Supplemental Fig. 7E). The extent of these phenotypes was highly variable among cardiomyocytes in the same sample, with mildly affected cardiomyocytes often bordering severely affected cardiomyocytes in a mosaic pattern. This mirrored the cellular heterogeneity observed by COX and SDH histochemistries and TEM in prior reports (Wang et al, 1999) (Supplemental Fig. 7B). Notably, these mitochondrial phenotypes were milder in a Tfam mKO; Dele1 KO heart sample compared to two Tfam mKO; Dele1+ hearts, suggesting that the DELE1 mt-ISR likely does not protect against these mitochondrial defects (Fig. 4J).
Considered together, mitochondrial ultrastructure was distinct among the four models, although each resulted in disruption of the IMM. The DELE1 mt-ISR did not reverse the underlying mitochondrial phenotypes, excepting the electrolucent mitochondria in the C10 G58R model. Thus, the DELE1 mt-ISR does not mitigate most structural abnormalities caused by mitochondrial stress.
The mt-ISR mediates a core transcriptional response to diverse mitochondrial stressors in striated muscle
To obtain a global view of the effect of the DELE1 mt-ISR on striated muscle, we performed transcriptomics in the hearts of three models that survived past weaning: C10 G58R, C10 S59L, and Tfam mKO. Despite the diversity of mitochondrial stress in these models, they shared 111 mito-stress DEGs in the heart, of which 51 (46%) were DELE1-dependent (hereafter, referred to as the DELE1 mt-ISR heart signature) (Fig. 5A – C and Supplemental Fig. 8A and B), with DELE1-dependency defined by the intersection of DEGS, as depicted in (Supplemental Fig. 1C). An additional 39 DELE1-dependent DEGs were shared in 2 of 3 models (Fig. 5B and Supplemental Fig. 8A). As an alternative approach to defined DELE1-dependent DEGs, we calculated the proportion of shared mito-stress DEGs that were at least 50% DELE1-dependent. This yielded a similar gene set of 57 genes (including all 51 DELE1 mt-ISR signature genes) (Supplemental Fig. 8C and D). Notably, the percent DELE1 dependence for genes in the DELE1 mt-ISR heart signature was similar regardless of the primary mitochondrial stress (Fig. 5D). Likewise, considering each model individually, a similar proportion of DEGs were DELE1-dependent (18 – 33%), indicating that the DELE1 mt-ISR accounts for a substantial portion of the overall transcriptional response to mitochondrial stress in each of the three models (Fig. 5E). Considered together, these results indicate that a common DELE1-dependent mechanism mediates signaling in response to diverse stressors such as mitochondrial protein unfolding and decreased mtDNA maintenance.
Overall, the core DELE1 mt-ISR had several recognizable components, including: (1) transcriptional regulation (with Atf5 having the highest fold-change in this group in all models); (2) amino acid transport and biosynthesis (particularly, of pathways for serine, glycine, asparagine, and proline biosynthesis) (13/51, 25% of genes); (3) protein translation, including amino acid tRNA synthetases, tRNA export (by Xpot), and protein synthesis re-initiation (by Eif3c) (12/51, 24% of genes) (Guan et al, 2017); and (4) mitochondrial 1C metabolism (which also intersects with serine and glycine metabolism and, through NADPH production, proline metabolism) (Ducker & Rabinowitz, 2017; Ducker et al, 2016) (Fig. 5C). Strikingly, nearly half of the genes in the core DELE1 mt-ISR signature were directed at promoting protein synthesis, as discussed further below.
These genes also overlapped extensively with those previously described as part of mitochondrial stress responses in mitochondrial myopathies, including Atf4, Atf5, Mthfd2, and Lonp1, all of which had > 81% DELE1-dependency in all three models (Fig. 5D) (Anderson et al, 2019; Tyynismaa et al, 2010; Dogan et al, 2014; Kühl et al, 2017; Nikkanen et al, 2016). Others previously associated with mitochondrial stress responses were either inconsistently elevated by mitochondrial stress or inconsistently DELE1-dependent. Ddit3 (also known as, Chop), Gdf15, and myc, for instance, was strongly DELE1-dependent in some but not other models. The mitokine Fgf21, by contrast, showed a high DELE1 dependence (>83%) in all models but only increased > 2-fold in C10 G58R hearts. Gpx4, which was found to be regulated by the OMA1-DELE1 pathway in Cox10 cKO hearts (Ahola et al, 2022), was elevated by about 50% at the mRNA and protein levels across models tested but was not consistently DELE1-dependent (reaching nominal significance only in mitochondrial proteomics data from C10 G58R) (Supplemental Fig., 9A – D). Thus, DELE1 accounts for upregulation of many but not all classic markers of mitochondrial stress in mouse striated muscle, in response to diverse mitochondrial stressors.
Notably, a substantial proportion of the core DELE1 mt-ISR genes encode mitochondrial proteins (11/51, 21.6%). These were enriched for genes involved in metabolism (proline synthesis, serine/glycine biosynthesis, and 1C metabolism), in addition to three involved in quality control: Lonp1, encoding a matrix quality control AAA+ protease; Ghitm (also known as Tmbib5), recently identified to encode a H+/Ca2+ antiporter (Austin et al, 2022; Zhang et al, 2022; Patron et al, 2022); and Slc25a39, which was recently identified to encode a glutathione transporter (Wang et al, 2021; Shi et al, 2022). We compared this set to DELE1-dependent proteins in mitochondrial proteomes from C10 G58R and Tfam mKO mice (Fig. 5F). Notably, 6 of 7 detected mitochondrial proteins in this group were found to significantly increase with stress and were >91% DELE1-dependent at the protein level (Fig. 5G and H, proteins overlapping with Common DELE1 DEGs in bold). The exception was AKR1B7, which has multiple cellular locations in addition to mitochondria. Thus, DELE1-dependent changes in gene expression at the transcript level are largely reflected in the mitochondrial proteome in diverse models of mitochondrial stress.
In contrast to these DELE1 mt-ISR regulated genes, total mitochondrial protein levels of OPA1 and OMA1 were differentially regulated in the C10 G58R hearts and Tfam mKO hearts. Whereas OMA1 levels were decreased in C10 G58R hearts, consistent with its self-cleavage on activation (Fig. 5I), OMA1 levels were higher in Tfam mKO hearts than controls (Supplemental Fig. 9E and F). These results suggest that in the context of chronic stress, absolute levels of OMA1 and OPA1 are not reliable biomarkers for the OMA1-DELE1 mt-ISR activation, in contrast to ratio of OPA1 cleavage products and upregulation of DELE1-dependent genes.
The correspondence between transcriptional and protein level regulation for these core DELE1 mt-ISR genes prompted us to consider the inverse scenario: is the mitochondrial proteome transcriptionally regulated by stress independently of the DELE1 mt-ISR? Strikingly, we found that DELE1 accounted for all transcriptionally driven increases in the mitochondrial proteome of greater than 2-fold in C10 G58R hearts compared to control (Fig. 5I)). Similar results were obtained in Tfam mKO hearts, in which DELE1 accounted for all the transcriptionally driven increases in the mitochondrial proteome, with the exceptions of TIMM10, PRDX6, COMTD1, and MTHFD2 (Supplemental Fig. 9E and F). Notably, except for TIMM10 (in Tfam mKO) and IMMP2L (in C10 G58R), all increases in proteases or chaperones were either DELE1-dependent (as in the case of LONP1, HSPA9, and HSPE1) or were likely post-transcriptional (Supplemental Fig. 9G and H). This suggests that the DELE1 mt-ISR is the principal mito-nuclear signal mediating the mito-UPR in striated muscle.
The DELE1 mt-ISR upregulates anabolic pathways that run through the mitochondrial matrix
Many of the amino acid biosynthesis pathways upregulated as part of the core DELE1 mt-ISR pass through the mitochondria, including those involved in asparagine synthesis (from the TCA intermediate oxaloacetate via aspartate), proline synthesis, and glycine synthesis (generated in the mitochondrial matrix from serine through the mitochondrial 1C metabolism pathway) (Fig. 6A, core genes in red). Flux through these interconnected pathways may be altered by OXPHOS dysfunction due, in part, to reductive stress in the mitochondrial matrix, as CI (and thus OXPHOS as a whole) is responsible for most of the NADH oxidation in the mitochondrial matrix. Consistent with reductive stress at the tissue level in adult C10 G58R hearts, NADP+ levels were significantly decreased and NAD+ levels trended toward decreased, in an untargeted metabolomic experiment (Fig. 6B).
We considered whether the OMA1-DELE1 mt-ISR may compensate for mitochondrial stress by upregulation of the key enzymes identified by transcriptomics and mitochondrial proteomics. To assess this in adult C10 G58R hearts, we used Oma1 ASO knockdown strategy we employed previously (Shammas et al, 2022), as Dele1 KO and Oma1 KO cause early death in this model. Among the named metabolites in the untargeted metabolomics dataset, 3-phosphoserine (3-PS) had the greatest fold-change, increasing >100 fold in the hearts of C10 G58R mice compared to control mice (Fig. 6C and Supplemental Fig. 10A). This increase was blocked by Oma1 KD, indicating it was dependent on the OMA1-DELE1 mt-ISR. This same pattern was also seen by targeted steady-state metabolomics in the hearts of P28 C10 G58R mice, and, to a lesser degree, in P56 Tfam mKO mice, although it did not reach significance in these models after correction for multiple comparisons (Fig. 6C and Supplemental Fig. 10B and C).
Notably, 3-PS is produced by two enzymes, PHDGH and PSAT1, the gene expression of which was strongly upregulated by the DELE1 mt-ISR in all models (Fig. 5C). These enzymes lie at a branch in glycolysis, in which glucose-derived carbons proceed to pyruvate, the TCA cycle, and ultimately OXPHOS or for the biosynthesis of serine and its derivates, such as glycine and 1C metabolism intermediates. The upregulation of PHDGH and PSAT1 and consequent increase in 3-PS are consistent with the hypothesis that a principal outcome of the OMA1-DELE1 mt-ISR is to shunt carbon from the glycolysis intermediate 3-PG toward biosynthesis.
Another potential carbon source for 3-PS synthesis is glutamine through the TCA cycle and gluconeogenesis. It is notable that two mitochondrial matrix enzymes, GPT2 (promoting glutamine entry into the TCA cycle via glutamate and oxaloacetate) and PCK2 (promoting gluconeogenesis from the TCA intermediate oxaloacetate) were increased by the DELE1 mt-ISR in C10 G58R hearts, and PCK2 was also increased in Tfam mKO hearts (Fig. 5B, G, H and Fig. 6A). Thus, the DELE1 mt-ISR may additionally push glutamine toward serine biosynthesis, as has been observed in rapidly dividing cancer cells with high biosynthetic needs (Vincent et al, 2015).
3-PS is the precursor for serine biosynthesis (Fig. 6A). Serine, in turn, is used for glycine biosynthesis and is the chief 1C donor for 1C metabolism (Ducker & Rabinowitz, 2017). Under basal conditions, most of the 1C metabolism flux from serine goes through the mitochondrial 1C metabolism pathway, with mitochondria exporting formate used for de novo purine and thymidine biosynthesis and the regeneration of methionine (after additional transformations) (Ducker et al, 2016). Mitochondrial 1C metabolism is also critical for generating the mitochondrial NAPDH pool needed for glutathione regeneration and proline synthesis, through the DELE1-responsive enzyme ALDH18A1. We, therefore, asked whether the OMA1-DELE1 mt-ISR helps maintain the mitochondrial 1C metabolism pathway in the setting of mitochondrial stress. To do so, we evaluated the levels of two metabolites AICAR and S-AICAR, precursors in purine synthesis, that are known to increase following blocks in mitochondrial 1C flux (particularly at MTHFD2) (Ducker et al, 2016). Consistent with the OMA1-DELE1 mt-ISR maintaining mitochondrial 1C flux in the setting mitochondrial stress, AICAR and S-AICAR levels remained baseline in C10 G58R mice but increased significantly when the OMA1-DELE1 mt-ISR was silenced, suggesting a partial block in the pathway in the absence of the mt-ISR (Fig. 6D). Thus, likely by upregulating mitochondrial 1C metabolism enzymes such as MTHFD2 and SHMT2 (and the upstream serine biosynthesis pathway), the OMA1-DELE1 mt-ISR may circumvent a block in the mitochondrial 1C metabolism pathway in the setting of mitochondrial stress.
In addition to serine and glycine biosynthesis, the DELE1 mt-ISR upregulates several amino acid biosynthesis and uptake pathways, including proline synthesis and asparagine biosynthesis, which connect directly with mitochondrial metabolism (Fig. 6A). We next evaluated whether these DELE1-dependent gene expression changes resulted in a steady-state change in amino acid levels in the hearts of adult C10 G58R (from untargeted metabolomics) and Tfam mKO mice (from targeted metabolomics). In both models, “aminoacyl-tRNA biosynthesis” was the most enriched KEGG metabolite set among mt-ISR dependent metabolites (Supplemental Fig. 10A and B). DELE1-dependent amino acids included proline, asparagine, and threonine in both models, and glycine, serine, leucine, phenylalanine, and glutamate in at least one of the models (Fig. 6E and F and Supplemental Fig. 10A and B). These DELE1-dependent amino acids all increased with stress.
We also examined amino acid levels in juvenile (P28) C10 G58R mice with one or no copies of Dele1 (Fig 6G and Supplemental Fig. 10C). In contrast to the adult C10 G58R mice, there were no significant changes in the abundance of steady-state amino acids levels, except for glycine (which significantly increased with stress) and glutamine (which decreased with stress). The change in glutamine was significantly DELE1-dependent, whereas the change in glycine trended in the direction of DELE1 dependence but did not reach significance after correcting for multiple comparisons. The relatively small effect on the steady-state metabolome in the rapidly growing animal could be due to increased utilization of amino acids, particularly if amino acid abundance is one of the factors limiting growth in the C10 G58R animals. Interestingly, the C10 G58R; Dele1 KO animals also showed high variability in steady-state tissue amino acid levels, which may reflect loss of homeostasis in animals that are at or nearing the end-stage of their life.
Considered together, these data suggest that the OMA1-DELE1 mt-ISR upregulates amino acid levels in the adult heart under mitochondrial stress, including four that are synthesized through pathways that are closely connected to mitochondrial metabolism: proline, asparagine, serine, and glycine. The steady-state increase of these four amino acids is likely driven by the DELE1 mt-ISR dependent upregulation of the enzymes responsible for their biosynthesis. That the upregulation of these amino acids is coordinated with the upregulation of their corresponding amino acid tRNA synthetase (i.e., proline with Eprs, asparagine with Nars, serine with Sars, glycine with Gars) additionally suggests that they may be upregulated to maintain adequate levels of tRNA-charged amino acids for protein synthesis (Fig. 5C and 6A).
The DELE1 mt-ISR is similar in heart and skeletal muscle
We next asked whether the core transcriptional components for the DELE1 mt-ISR identified in the heart are conserved across mouse tissues. We compared the DELE1-dependent gene signatures among three mitochondrial enriched tissues from C10 G58R mice, the heart, the gastrocnemius, and the liver, as well as BAT from wildtype mice subjected to cold stress (Fig. 7A). Although OMA1 is activated strongly in the liver of C10 G58R mice (Shammas et al, 2022), the mt-ISR transcriptional response was surprisingly weak, with no DELE1-dependent DEGs at P28 and a small number of OMA1-dependent DEGs in tissue for C10 G58R mice evaluated at ∼1 year, following knockdown of Oma1 with an ASO (Supplemental Fig. 11). Altogether, two OMA1 or DELE1-dependent genes, Fgf21 and Psat1, were shared among all tissues, suggesting that these may represent the most robust markers for the OMA1-DELE1 mt-ISR across mouse tissues (Fig. 7A).
Among the mouse tissues, the heart and gastrocnemius showed the greatest overlap: 32 out of 51 (63%) mt-ISR heart signature genes were found in the gastrocnemius (Fig. 7B and C, and Supplemental Fig. 12A and B), including nearly all pro-anabolic genes diagrammed in (Fig. 6A).
Exceptions were Iars, Cars, Mars, Eprs, and Shmt2, which were strongly DELE1-dependent and trended toward being upregulated by C10 G58R stress but did not reach significance (Supplemental Fig. 12C). Interestingly, C10 G58R; Dele1 KO mice also showed significant upregulation of catabolic genes, including those encoding the transcription factor Foxo1a and the atrogenes Fbxo32 (also known as, MAFbx) and Trim63 (also known as, MuRF1), suggesting that the DELE1 mt-ISR may suppress a catabolic program in skeletal muscle in addition to upregulating a pro-anabolic program (Supplemental Fig. 12D).
We next compared DELE1-dependent genes in skeletal muscle from the mouse C10 G58R mitochondrial myopathy model with the transcriptional signature of muscle from mitochondrial myopathy patients from three previously published datasets (Hathazi et al, 2020; Pirinen et al, 2020; Kalko et al, 2014). The patients in these datasets were of different ages and had different causes of their mitochondrial myopathy, but 11 genes in the mouse DELE1-dependent signature were upregulated by at least 2-fold averaged across the three studies (Fig. 7C). These included genes involved in biosynthesis of serine (PHGDH and PSAT1), proline (PYCR1), and asparagine (ASNS), as well as gluconeogenesis (PCK2), which may facilitate additional carbon sources for serine biosynthesis, as discussed above. The signature additionally included the amino acid transporters, SLC7A11 and SLC7A1, for cystine and positively charged amino acids, respectively, and the mitokine FGF21. This suggests that key components of the DELE1 mt-ISR promoting anabolism in the setting of mitochondrial stress are conserved to humans and upregulated by diverse causes of mitochondrial myopathies.
The DELE1 mt-ISR maintains protein synthesis and proteostasis in striated muscle under mitochondrial stress
The findings so far suggest that the DELE1 mt-ISR upregulates pathways to maintain protein synthesis intermediates in the setting of mitochondrial stress. This would be predicted to promote net protein synthesis by facilitating translation elongation (Fig. 7D). However, acutely the ISR also limits the availability of the ternary complex required for translation initiation, which would be predicted to slow the net protein synthesis rate (Pakos-Zebrucka et al, 2016). While these two actions of the ISR may seem opposed, they have in common the promotion of well-regulated protein synthesis under metabolic stress. By simultaneously restricting the number of ribosomes that can initiate translation and increasing protein synthesis intermediates to maintain translation elongation, the mt-ISR may minimize ribosome stalling and/or mistranslation, thereby limiting translation associated protein misfolding (Stein & Frydman, 2019; Stein et al, 2022). This suggests that the overall effect of the mt-ISR in mitochondrial myopathy may not be to slow net protein translation per se but to maintain the quality of protein translation in the setting of mitochondrial stress.
To directly assess the net effect of the DELE1 mt-ISR on protein synthesis in striated muscle, we performed the SUnSET assay in the heart and gastrocnemius muscle of the C10 G58R mice on the Dele1+ or Dele1 KO backgrounds. Mice in each group were injected with puromycin, a tRNA aminoacyl analog that is incorporated into the elongating polypeptide, 30 minutes prior to sacrifice, and puromycylated peptides were detected by immunoblotting (Schmidt et al, 2009) (Fig. 7E and F). In C10 G58R mice, protein synthesis trended towards an increase in the heart and a decrease in gastrocnemius but did not differ significantly from control mice at P21 and P28 (Fig. 7E and F). Importantly, although Dele1 KO normalized pS51-eIF2α in C10 G58R mice, as expected (Supplemental Fig. 12E), it did not increase net protein synthesis in the heart or gastrocnemius (Fig. 7E and F). We also considered the ratio of protein synthesis in the gastrocnemius to the heart for individual mice, in order to control for sources of interindividual variability. Notably, the C10 G58R; Dele1 KO had the lowest heart-to-gastrocnemius ratio among groups, which reached statistical significance in comparison to control animals at the day 21 timepoint (Fig. 7F, bottom graph). Together these data suggest that the DELE1 mt-ISR does not have a net inhibitory effect on protein synthesis in stressed striated muscle, despite elevated pS51-eIF2α, and trended toward maintaining protein synthesis in skeletal muscle.
Having found the DELE1 mt-ISR did not decrease the net protein synthesis rate, we next considered its effect on proteostasis in skeletal muscle, using confocal microscopy. Notably, C10 G58R; Dele1 KO but not C10 G58R; Dele1+ gastrocnemius muscle contained aggregates of ubiquitinated proteins that co-localized with p62/SQSTM1, a ubiquitin binding protein that sequesters misfolded proteins and can function as an autophagy adaptor (Supplemental Fig. 13A and B). In some fibers from C10 G58R; Dele1 KO, these aggregates were so numerous that they appeared confluent by diffraction-limited light microscopy, suggesting proteostatic collapse within the myofiber (Fig. 7G and H).
Newly translated proteins are particularly vulnerable to protein misfolding, and the rate of protein translation can affect protein misfolding. To determine if protein aggregation within myofibers is associated with local changes in protein synthesis, we additionally assessed the gastrocnemius of C10 G58R; Dele1 KO mice that were injected with puromycin 30 min prior to sacrifice (Fig. 7I - K). Myofibers with ubiquitin aggregates were again observed in C10 G58R; Dele1 KO mice but not the other genotypes (Supplemental Fig. 13C). Notably, the muscle fibers with numerous aggregates had higher protein synthesis rates than other fibers in the same tissue (with 171.2% higher puromycin intensity on average). These myofibers also had a significantly smaller cross-sectional area (CSA) (mean CSA: 330.0 vs. 446.9 μm2), suggesting that they have failed to grow or are undergoing atrophy. Interestingly, individual ubiquitin protein aggregates also co-localized with puromycylated polypeptides, suggesting that the ubiquitin aggregates may form near sites of active translation. The puromycin immunostaining was likely specific for puromycylated polypeptides, as no signal was present in a negative control C10 G58R; Dele1 KO mouse not injected with puromycin (Supplemental Fig. 13C, right most panel). These findings suggest that the DELE1 mt-ISR is important for maintaining translation-associated proteostasis in striated muscle under mitochondrial stress.
Considered together, these findings suggest that the DELE1 mt-ISR reshapes the metabolic network in stressed striated muscle to promote anabolism, including the continued production of intermediates for protein synthesis. We speculate that loss of the DELE1 mt-ISR may lead to loss of protein translation control and underlie the observed proteostatic collapse, decreased growth, and decreased survival in in models of early-onset myopathy, such as IMMD.
Discussion
By comparing four myopathy/cardiomyopathy models resulting from diverse mitochondrial stresses, including protein unfolding and mtDNA depletion, we identified that the DELE1 mt-ISR is the predominant mitonuclear signaling response to mitochondrial stress in striated muscle. Although the primary source of mitochondrial stress was distinct in each model, they converged on disruption of the IMM, a central component of the OXPHOS system, which was sensed by OMA1 to activate the mt-ISR through DELE1 (Fessler et al, 2020; Guo et al, 2020). As OXPHOS disruption can affect the biosynthetic function of mitochondria, through decreased turnover of redox equivalents such as NADH (Luengo et al, 2021), the integrity of the IMM may be an important predictor of disruptions in mitochondrial metabolism. By sensing disruption of the IMM, the OMA1-DELE1 pathway may anticipate these disruptions to mitochondrial metabolism.
Notably, the mt-ISR did not correct the underlying mitochondrial structural or respiratory chain defects but rather compensated for OXPHOS dysfunction to maintain biosynthesis in the setting of stress, particularly through the upregulation of pathways for the biosynthesis of aminoacyl-tRNAs. It is notable that the ISR in yeast is largely a homeostatic response, in which uncharged tRNAs are sensed by GCN2, which, in turn, limits translation initiation, and triggers a transcriptional response to increase the synthesis of aminoacyl-tRNAs (Postnikoff et al, 2017). In this context, the OMA1-DELE1-HRI may be thought of as a predictive homeostatic response; it anticipates a limitation of biosynthetic intermediates in the setting of diverse forms of mitochondrial stress and responds by upregulating metabolic pathways to maintain biosynthesis. This response may not slow net protein synthesis per se but may promote the overall translation fidelity by reducing the chance of ribosome stalling or mistranslation.
Consistently, we found that the DELE1 mt-ISR did not slow net protein synthesis in the stressed heart and gastrocnemius, and, in fact, showed a trend toward promoting net protein synthesis in the gastrocnemius. This is also consistent with recent data from the Dars2 cKO model, in which the ISR only slowed translation transiently in the setting of an exaggerated ISR response to chronic mitochondrial stress in the heart but did not mediate a prolonged decrease in translation (Kaspar et al, 2021). It is tempting to speculate that loss of translational control following Dele1 KO may also explain the proteostatic collapse we observed in the striated muscle of C10 G58R; Dele1 KO mice, as ribosome stalling and mistranslation are known to promote protein misfolding (Stein & Frydman, 2019; Stein et al, 2022). Consistently, myofibers with the most severely disrupted proteostasis in C10 G58R; Dele1 KO mice had the highest rates of translation.
The DELE1 mt-ISR was particularly critical for survival in two models, C2/10 DKO and C10 G58R, that experienced mitochondrial stress onset during the rapid period of growth in the first weeks of life. The survival deficit was most dramatic in C2/10 DKO mice. We speculate that the DELE1 mt-ISR is particularly important for maintaining the biosynthetic capacity of stressed striated muscle during periods of rapid hypertrophic muscle growth. It is notable in this context that demands for protein synthesis intermediates are especially high in the first weeks of life in the mouse, as hypertrophic muscle growth accounts for half of the eight-fold increase in body mass during the first three weeks of life (White et al, 2010; Gokhin et al, 2008). This may explain why many of the pathways upregulated by the DELE1 mt-ISR in postmitotic striated muscle (such as serine/glycine synthesis, mitochondrial 1C metabolism, and proline synthesis) are also frequently upregulated in rapidly dividing cancer cells (Westbrook et al, 2022; Ducker et al, 2016; Geeraerts et al, 2021; Nilsson et al, 2014). In both cases, there is a strong demand for protein synthesis intermediates to increase biomass. Although striated muscle may be able to meet this need without upregulation of these pathways under basal conditions, in the setting of mitochondrial dysfunction, metabolic pathways may need to be rebalanced to maintain an uninterrupted supply of biosynthetic intermediates.
The dramatic survival benefit observed in the C10 G58R and C2/10 DKO models contrasted with the more modest survival benefit seen in the Tfam mKO and C10 S59L models. We speculate that the DELE1 mt-ISR is less important for survival in these models because the biosynthetic demands in striated muscle of juvenile and adult mice are less than those of neonatal mice. These demands are still present in the adult, however, and the DELE1 mt-ISR may similarly protect the Tfam mKO and C10 S59L models by maintaining biosynthesis in the setting of mitochondrial stress. The biosynthetic needs in the adult heart may be related to protein synthesis or they may be related to intersecting metabolic pathways.
Glycine and cysteine, for instance, are important for glutathionine synthesis and redox homeostasis. In the Cox10 cKO, the DELE1 mt-ISR has been suggested to be important for redox homeostasis and prevention of ferroptosis (Ahola et al, 2022). In this context, it is noteworthy that among the 51 highly conserved genes across the models were the transporter for cystine, Slc7a11, which tends to increase intracellular cysteine levels (which contributes to glutathione synthesis together with glycine and glutamate), and the mitochondrial glutathione transporter, Slc25a39, which may also help prevent damage to membranes from lipid peroxidation and suppress ferroptosis. Likewise, serine, a 1C donor, is important for the de novo synthesis of nucleotides and the production of mitochondrial NADPH through the mitochondrial 1C metabolism pathway. In some models of mtDNA maintenance disorders like the Twinkle Deletor mouse, nucleotide synthesis through the 1C metabolism pathway may be particularly critical (Nikkanen et al, 2016). Thus, although the transcriptional response is similar in each model, the metabolic flexibility afforded by increased levels of key enzymes such as the NAD+-dependent PSAT1 and MTFHD2, may serve different biosynthetic needs at different developmental stages, and this may be reflected in downstream differences in the metabolome and proteome among the models.
Notably, the DELE1 mt-ISR transcriptional signature identified here overlapped extensively with that in other models of disrupted mtDNA maintenance or expression. Indeed, a similar response, identified first in Twinkle mutant mice (Tyynismaa et al, 2010), has been documented with disruptions at each step of mtDNA maintenance and expression, including mtDNA replication (Twinkle KO), mtDNA maintenance (Tfam KO), mtDNA transcription (Polrmt KO), mtRNA stability and processing (Lrpprc KO), and mtRNA translation (Mterf4 KO and Dar2 KO) (Dogan et al, 2014; Kühl et al, 2017). Our results from the Tfam mKO model strongly suggests that the DELE1 mt-ISR mediates this response resulting from decreased mtDNA expression or maintenance, generally. Thus, it is likely that the DELE1 mt-ISR underlies a transcriptional signature that it is seen in striated muscle across diverse forms of mitochondrial myopathy. As mtDNA mutations and disorders of mitochondrial maintenance are the most common causes of primary mitochondrial disorders (Gorman et al, 2015), the DELE1 mt-ISR may be an important response in most forms of mitochondrial myopathy. Consistently, we found extensive overlap between the DELE1 mt-ISR signature in the skeletal muscle of the IMMD mouse model of myopathy and genes upregulated in three cohorts of patients with mitochondrial myopathy, which included patients with mutations in Twinkle, TK2, and mtDNA (Hathazi et al, 2020; Pirinen et al, 2020; Kalko et al, 2014). This signature included genes involved in serine, proline, and asparagine biosynthesis, as well as the FGF21, which encodes a secreted mitokine that is widely used as a biomarker in mitochondrial myopathies (Lehtonen et al, 2016). This also suggests that FGF21 levels may provide a reliable marker of disruption at the IMM, sensed by the OMA1-DELE1 pathway.
Together our findings demonstrate a stereotyped DELE1-dependent response to diverse forms of mitochondria stress in mitochondrial myopathy. These mitochondrial stressors likely converge on disruption of the IMM and IMM-dependent OXPHOS. The response circumvents disruptions to biosynthetic pathways coupled to OXPHOS by rebalancing the metabolic network through a coordinated transcriptional program. This response is particularly critical during periods of rapid growth when biosynthetic demands are high. These findings suggest that interventions to promote the biosynthetic functioning of stressed striated muscle may be protective and caution against inhibition of the ISR in mitochondrial myopathy.
Materials and Methods
Mouse models
Mice were maintained on a 12-hour light/12-hour dark cycle, with food and water provided ad libitum unless otherwise stated. The Opa1Δs1/+ and Dele1+/- mice were generated using CRISPR/Cas9 endonuclease-mediated genome editing on a C57Bl6J background by the NHLBI Transgenic Core. The deletions were confirmed by Sanger sequencing (Eurofins). Ckmm-Cre (JAX stock #006475) and Tfamfl/fl mice (JAX stock #026123) were obtained from Jackson laboratory (Brüning et al, 1998; Hamanaka et al, 2013). The generation of C10 G58R, C10 G59L, C2/C10 DKO, and OMA1 KO mice were described previously (Liu et al, 2020; Shammas et al, 2022; Quirós et al, 2012). All animal studies were approved by the Animal Care Use Committee at the NINDS, NIH intramural research program. Both genders were used in all studies.
Nutritional support
Mice in the nutritional support group were weaned on P28 instead of P21. In addition to the regular chow on the racks, they received KMR milk replacer using a small syringe twice daily from Monday to Friday and once daily on Saturday and Sunday. Other dietary supplements, including plain soft chow, Dietgel 76A (ClearH2O), and bacon-flavored treats, were also provided on the cage floor ad libitum.
Cell Culture
Primary neonatal fibroblasts were generated using methods described previously (Liu et al, 2020). Primary neonatal fibroblasts generated from Opa1Δs1/Δs1 mice and from the wildtype littermates were treated with 20 μM CCCP or DMSO vehicle only for 16 hours.
Cold Experiments
Adult mice in the experimental group were transferred to individual plastic cages with pre-chilled water but without bedding or food in a 4 °C cold room while mice in the control group remain room temperature. After 9 hours of exposure, mice were anesthetized with isoflurane and euthanized by cervical dislocation. Interscapular BATs were harvested immediately.
Behavioral tests
Mouse forelimb grip strength was assessed using a BIOSEB instrument with grid attachment (catalog EB1-BIO-GS3). Three grip strength measurements were taken per mouse with 15-second resting periods between the trials. Composite phenotype scores were assigned based on the protocol described previously (Guyenet et al, 2010). All tests were performed by the same tester, who was blinded to the genotypes of the mice.
RNA microarray
RNA microarrays were performed and analyzed as described previously (Shammas et al, 2022). In brief, RNA was extracted from frozen mouse hearts, gastrocnemius muscles, livers, and BATs using the Direct-zol RNA Miniprep Kit (Zymo, catalog R2051), the RNeasy Fibrous Tissue Mini Kit (QIAGEN, catalog 74704), or the RNeasy Lipid Tissue Mini Kit (QIAGEN, catalog 74804). RNA expression was measured using the Clariom S Mouse microarray (Affymetrix) by the NHGRI Microarray Core. Transcriptome Analysis Console software (Affymetrix, version 4.0.1) was used to analyze the data with the default settings.
Immunoblotting
Immunoblotting and densitometric measurements were performed as described previously (Liu et al, 2020). In brief, mouse frozen hearts, BATs, and fibroblasts were lysed in RIPA buffer (Cell Signaling Technology, catalog 9806) with Protease/Phosphatase Inhibitor Cocktail (Cell Signaling Technology, catalog 5872). A buffer containing 20 mM Tris pH 7.8, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, 1% Triton X-100, 10% glycerol, 1 mM ethylenediamine tetraacetic acid and 1 mM dithiothreitol was used instead to lyse mouse frozen skeletal muscle. OPA1 bands on the blot were quantified using FIJI software (Schindelin et al, 2012). All other protein bands and total protein stains (LI-COR Biosciences, catalog 926-11016) were quantified using Image Studio v5.2 (LI-COR Biosciences).
Histological analysis
BATs were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) overnight and washed in PBS three times. Fixed tissues were sent to Histoserv (Germantown, MD) for paraffin embedding, microtome sectioning, and haematoxylin and eosin (H&E) staining by standard procedures.
Immunofluorescent Staining
Mice were anesthetized with isoflurane and transcardially perfused with PBS. Mouse tissues were dissected and frozen in chilled isopentane. 10 μm cross cryosections of the heart and of gastrocnemius mid-belly region were collected onto glass slides. Sections were washed with 0.1% Triton X-100 in PBS (PBST), blocked with 5% BSA in PBST for 1 hour at room temperature, and incubated in primary antibodies with 0.5% BSA in PBST overnight at 4 °C. Then, sections were washed in PBST and incubated in secondary antibody in PBST for 1-2 hours at room temperature. Slides were washed with PBST and PBS before coverslipped with ProLong Diamond Antifade Mountant (Invitrogen, catalog P36965) and sealed with nail polish. Images were obtained using Olympus FLUOVIEW FV3000 confocal laser scanning microscope.
Quantification of CSA of muscle fibers
Muscle fiber segmentation was performed using Cellpose 2.0 (Pachitariu & Stringer, 2022), deep learning program that utilizes human-in-the-loop training models to further automate the segmentation process, on laminin-labeled immunofluorescence images. After segmentation, CSA was quantified using LabelsToROIs of FIJI plugin (Waisman et al, 2021).
Mitochondrial isolation
Mitochondria were isolated from mouse heart tissues as described previously (Frezza et al, 2007).
Proteomics
Label-free quantitative proteomics of mitochondria isolated from mouse heart tissue was performed by the NINDS Proteomics Core Facility as described previously for most samples (Shammas et al, 2022). In brief, liquid chromatography-tandem mass spectrometry (LC-MS/MS) data acquisition was performed on an Orbitrap Lumos mass spectrometer (Thermo Fisher Scientific) coupled with a 3000 Ultimate high pressure liquid chromatography instrument (Thermo Fisher Scientific). Peptides were separated on an ES802 column (Thermo Fisher Scientific) with the mobile phase B (0.1% formic acid in acetonitrile) increasing from 3 to 22% over 70 minutes. The LC MS/MS data were acquired in data-dependent mode. For the survey scan, the mass range was 400-1500 m/z; the resolution was 120 k; the automatic gain control (AGC) value was 8e5. For C10 G58R and related genotype samples, a FAIMS interface was used. In this case the gradient MPB was increased from 3 to 20% over 63 minutes and the mass range of the MS1 scan was 375 - 1500 m/z. In all cases, the MS1 cycle time was set to 3 seconds. As many MS2 scans as possible were acquired within the cycle time. MS2 scans were acquired in ion-trap with an isolation window of 1.6 Da. Database search and mutant/WT ratio calculation were performed using Proteome Discovery 2.4 (Thermo Fisher Scientific) against Sprot Mouse database. Proteins were annotated as mitochondrial if they appeared in mouse MitoCarta3.0, and were additionally annotated with MitoPathways from MitoCarta3.0 (Rath et al, 2021).
Seahorse assays
Seahorse oxygen consumption-based measurements of CI and CIV activities from frozen mitochondria isolated from hearts were performed according to the protocol described previously (Osto et al, 2020). 0.4 μg/well of frozen mitochondria were used with Seahorse XF Pro Analyzer (Agilent Technologies).
ASO experiment
ASOs were synthesized at Ionis Pharmaceuticals as previously described (Seth et al, 2010; Shammas et al, 2022). Adult C10wt/wt; Oma1+/– mice were given weekly subcutaneous injections of PBS. Adult C10G58R/wt; Oma1+/– mice were given weekly subcutaneous injections of either a nontargeting (control) ASO or an OMA1-targeting ASOs. The mice were between 10.5 months and 13.5 months old. The ASOs were at a concentration of 5 mg/mL, and injections were dosed at 50 mg/kg. A total of 6 injections were administered per mouse over 6 weeks. Then, the mice were anesthetized with isoflurane and transcardially perfused with PBS, and their tissues were collected and flash-frozen in liquid nitrogen.
Metabolomics
Mice were anesthetized with isoflurane and transcardially perfused with PBS. Mouse hearts were harvested and freeze-clamped immediately. Metabolomics data of the ASO experiment was obtained by the Metabolomics Core at the University of Michigan using their non-targeted metabolomics platform with manual peak integration on named compounds and automated peak detection for other mass spectrometer signals. Binner for data reduction and RefMet database (https://doi.org/10.1093/bioinformatics/btz798) were used (Kachman et al, 2020). Metabolomics data of the C10 G58R and Tfam mKO experiments were obtained by Metabolomics Core Resource Laboratory at NYU Langone Health.
SUnSET assays
Measuring protein synthesis in mouse tissues was performed according to the protocol described previously (Ravi et al, 2020). In brief, puromycin 40 nmol/g of body weight was injected intraperitoneally to C10 G58R; Dele1 KO mice and their littermates. Mice were scarified after 30 minutes from the injection. Their tissues were collected and flash-frozen in liquid nitrogen. Immunoblotting was performed as described above.
Transmission Electron Microscopy of Mouse Heart
Mice were deeply anaesthetized and transcardially perfused with PBS. Hearts were rapidly dissected, and sub-millimeter pieces of tissue were excised from the left ventricle and immersed in freshly prepared fixative containing 4% glutaraldehyde and 2 mM calcium chloride in 0.1M sodium cacodylate buffer, pH 7.4 (Electron Microscopy Sciences, Hatfield, PA, USA [EMS]). In the case of tissue obtained for the C2/C10 DKO mutant, mice were anaesthetized with isoflurane and then transcardially perfused with 2% paraformaldehyde, 2.5% glutaraldehyde, and 2 mM calcium chloride in 0.1M sodium cacodylate buffer. Perfusion-fixed hearts were excised and submerged in storage fixative containing 2% glutaraldehyde in 0.1M cacodylate buffer. Hearts were immediately further dissected by cutting a 1 mm-thick coronal section at the midpoint of the heart using a mouse heart slicer matrix (Zivic Instruments, Pittsburgh, PA, USA). The wall of the left ventricle in the coronal slice was cut into submillimeter pieces with a razor blade, submerged in storage fixative and stored at 4°C until processing for EM.
For EM processing, pieces of tissue were rinsed with 0.1M sodium cacodylate buffer (cacodylate buffer) three times and then postfixed on ice with reduced osmium containing 1% osmium tetroxide (EMS) and 1% ferrocyanide (Fisher Scientific, Pittsburgh, PA, USA) in cacodylate buffer for one hour. After three, 5-minute rinses in cacodylate buffer, tissue was rinsed in 0.1N acetate buffer (pH 5.0-5.2) at room temperature and then en bloc stained overnight with 1% uranyl acetate (EMS) in acetate buffer at 4°C. Tissue was then rinsed in acetate buffer and dehydrated through a graded series of 10-minute ethanol rinses prior to infiltration in EmBED812 epoxy resin using the manufacturer’s hard resin formulation (EMS). Finally, tissue was embedded in flat embedding molds and resin was polymerized in a 60°C oven for 48 hours.
Ultrathin sections were cut to a thickness of 60-70 nm using an ultramicrotome (EM UC7, Leica Microsystems, Wetzlar, Germany) equipped with a diamond knife (DiATOME, Hatfield, PA, USA). Sections were picked up on formvar coated 200-mesh or 1 mm-slot copper grids (EMS), and post-stained with 3% Reynold’s lead citrate (EMS) for 1 minute. Sections were viewed using a JEOL1400 Flash transmission electron microscope (JEOL USA, Inc., Peabody, MA, USA) operated at 120 KV. Images were acquired using a 29 Mpix CMOS detector (Advanced Microscopy Techniques, AMT, Danvers, MA, USA). Images from serial sections were aligned using the TrakEM2 plugin of Fiji image analysis software (Schindelin et al, 2012) which is a version of the open-source image analysis software, Image J2 (Rueden et al, 2017). For display, linear adjustments to light and dark levels in greyscale images were made Adobe Photoshop 2023 and figures were prepared using Adobe Illustrator 2023 (Adobe Inc., San Jose, CA, USA).
Semi-automated analysis of mitochondria size, shape, and ultrastructural features in TEM images
Mitochondria were auto-segmented using MitoNet, a deep learning segmentation model, operated with Python software, using the napari plungin, called empanda (Conrad & Narayan, 2023). Structural features of mitochondria in TEM images were analyzed from two mice of each genotype (except for the Tfam mKO for which only one littermate of control and Tfam mKO, Dele1 KO were available). To carry out the analysis, images of at least two areas of tissue for each littermate were recorded at 2000 x direct magnification which encompassed a 550 µm2 field of view (examples for each genotype are shown in Supplemental Fig. 4 - 7). These areas were selected based on being located towards the interior of the tissue away from edges cut during dissection, and areas where the plane of the thin section was semi-longitudinal with respect to the muscle fibers, rather than transversely oriented. Within these areas, images of at least five subareas were acquired at 5000 x direct magnification, each of which encompassed an 87 μm2 field of view (examples are shown in Supplemental Fig. 4 – 7). Two or more of these 5000 x images were randomly selected for structural analysis using MitoNet segmentation. For each image, labels were automatically assigned to mitochondria detected in the TEM image by empanada-napari. The segmentation labels were manually proofread and corrected as needed and then the set of labels for each image was used to log the size features of each mitochondria including area, major and minor axis lengths, and aspect ratio into Excel (Microsoft Corporation, Redmond WA, USA). A minimum of 600 mitochondria per genotype were analyzed. The same labels created in empanada-napari were used to tabulate ultrastructural features of individual mitochondria in the control and mutant genotypes. With labels overlayed on the TEM image, each mitochondrion was examined and manually scored as normal or abnormal, and structural features noted in the Excel file that also contained the shape features logged for each mitochondrion. The percent of mitochondria with various structural features per genotype were graphed using GraphPad Prism 10.1.0 (316) version for Windows (GraphPad Software, Boston, MA, USA, www.graphpad.com).
Statistics
Statistical analyses were performed using Prism (GraphPad), the statsmodels 0.14.1 Python module (for metabolomics and proteomics analysis), or the Transcriptome Analysis Console (TAC) (for analysis of microarray gene expression data). To define stress-dependent changes, two-tailed t-tests with pooled variance were performed comparing the stress; Dele1+ group vs. the control group. Multiple testing was corrected for using the Benjamini/Hochberg False Discovery Rate (FDR) method. Significant changes were defined as having a fold-change of >= 2 or <= 2 and an FDR <= 5%. DELE1-dependent changes were defined as significant stress-induced changes that were also significantly changed in the comparison of the stress; Dele1 KO vs. stress; Dele1+ (applying the same fold-change and FDR cutoffs) with a fold change in the opposite direction to the Dele1+ group vs. the control group, consistent with reversion toward control. Percent DELE1 dependence was defined as the percent decrease or increase for Dele1 KO vs. stress; Dele1+ divided by the percent increase or decrease for Stress; Dele1+ vs control. Set analysis for metabolomics data was performed using MetaboAnalyst 6.0 (https://www.metaboanalyst.ca/MetaboAnalyst/). In all figures,*, **, ***, and **** correspond to pvalues of <= 0.05, <= 0.01, <= 0.001, <= 0.0001, respectively.
Data availability
Microarray data will be deposited in the NCBI’s Gene Expression Omnibus (GEO) Database. Analyzed data is available in Supplemental Tables 1 - 3.
Supplemental Figure Legends
Supplemental Tables
Table 1. Transcriptomics from hearts of three myopathy/cardiomyopathy mouse model.
Table 2. Mitochondrial proteomics from hearts of three myopathy/cardiomyopathy mouse model.
Table 3. Metabolomics from hearts of two myopathy/cardiomyopathy mouse model, Tfam mKO and C10 G58R.
Acknowledgements
We thank Sandra Lara, Dr. Jung-Hwa Tao-Cheng, and the NINDS EM Facility for technical assistance with TEM. We thank Dr. Abdel Elkahloun and the NHGRI/DIR Microarray Core for technical assistance with RNA expression studies. We thank the NINDS Proteomics Core Facility for the label-free quantitative proteomics data acquisition. We thank Dr. Chengyu Liu and the NHLBI Transgenic Core for assistance in generating transgenic mice. We thank Drs. Pedro M. Quirós and Carlos Otin Lopez for providing the OMA1 KO mice. We thank Dr. James J. Faust (Evident) for technical assistance with confocal microscopy. We thank Maureen Kachman and the Michigan Regional Comprehensive Metabolomics Resource Core for help with metabolic experiments of adult C10 G58R mice treated with Oma1 ASOs.
We thank Ionis Pharmaceuticals for providing control and Oma1 targeted ASOs that were used in in vivo experiments. We thank Dr. Richard Youle for critical reading of the manuscript and insightful comments. The linked image (https://en.wikipedia.org/wiki/Laboratory_mouse#/media/File:Vector_diagram_of_laboratory_mouse_(black_and_white).svg) was used in a modified form in some of the figures and is covered under a CC BY-SA 4.0 license. This work was supported by the Intramural Research Program of the NINDS, National Institutes of Health.
Footnotes
Conflict-of-interest statement
The authors declare that they have no conflict of interest.